Feyza Gelebek Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Feyza Gelebek Yilmaz has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Abdullah Emre Yildirim
Gaziantep Univ, Sch Med, Dept Gastroenterol, Gaziantep, Turkey
1 shared publication- Akif Sirikci
Department of Radiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
1 shared publication - Emin Akdoğan
Department of Radiology, Gaziantep University School of Medicine, Gaziantep, Turkey
1 shared publication - Haluk Sen
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
1 shared publication - Ilker Seckiner
Urology Department, School of Medicine, Gaziantep University, Gaziantep, Turkey.
1 shared publication J.W. Gorrod
1 shared publication
Latest Publications
- Open Access
- 16 April 2024
- Published by Springer Nature in Surgery Today
- Vol. 54 (10) , 1265-1271
Ultrasound-based predictive indicators for treatment outcomes in pediatric vesicoureteral reflux
Purpose: To evaluate the effectiveness of preoperative ultrasound (US) measurements in predicting pediatric vesicoureteral reflux (VUR) treatment outcomes. Methods: This prospective study enrolled 35 patients (53 renal units) aged 1–16 years who underwent subureteric injection therapy for primary VUR between July 2020 and June 2022. Preoperative ultrasound examinations measured the bladder wall thickness at the ureteral orifice, ureteral submucosal tunnel length, distal ureteral diameter, patient demographics, VUR grade, presenting complaints, bladder–bowel dysfunction, and renal scarring, and the impact of these variables on treatment success was analyzed. Results: Among the patients, 91.4% were female, with a mean age of 6.83 ± 3.84 years. A comparison between the treatment success and failure groups revealed no significant differences in the age, sex, VUR grade, laterality, bilaterality, presenting complaints, bladder–bowel dysfunction, bladder wall thickness, or distal ureteral diameter (p > 0.05). However, renal scarring occurred in 16 (38.1%) patients in the treatment success group and 10 (90.9%) in the treatment failure group (p = 0.002). The treatment failure group had shorter detrusor-to-ureteral orifice distances and smaller detrusor-ureteral orifice distance-to-distal ureteral diameter (D/U) ratios than that of the success group (p = 0.004 and p = 0.006, respectively). Patients with a detrusor-to-ureteral orifice distance < 7.4 mm had an 81.82% likelihood of treatment failure. Conclusion: Ultrasound measurements of the detrusor-to-ureteral orifice distance and D/U ratio proved reliable in predicting the success of endoscopic subureteric injection therapy for VUR.
- 16 April 2024
- Published by Springer Nature in Surgery Today
- Vol. 54 (10) , 1265-1271
Open AccessUltrasound-based predictive indicators for treatment outcomes in pediatric vesicoureteral reflux
Purpose: To evaluate the effectiveness of preoperative ultrasound (US) measurements in predicting pediatric vesicoureteral reflux (VUR) treatment outcomes. Methods: This prospective study enrolled 35 patients (53 renal units) aged 1–16 years who underwent subureteric injection therapy for primary VUR between July 2020 and June 2022. Preoperative ultrasound examinations measured the bladder wall thickness at the ureteral orifice, ureteral submucosal tunnel length, distal ureteral diameter, patient demographics, VUR grade, presenting complaints, bladder–bowel dysfunction, and renal scarring, and the impact of these variables on treatment success was analyzed. Results: Among the patients, 91.4% were female, with a mean age of 6.83 ± 3.84 years. A comparison between the treatment success and failure groups revealed no significant differences in the age, sex, VUR grade, laterality, bilaterality, presenting complaints, bladder–bowel dysfunction, bladder wall thickness, or distal ureteral diameter (p > 0.05). However, renal scarring occurred in 16 (38.1%) patients in the treatment success group and 10 (90.9%) in the treatment failure group (p = 0.002). The treatment failure group had shorter detrusor-to-ureteral orifice distances and smaller detrusor-ureteral orifice distance-to-distal ureteral diameter (D/U) ratios than that of the success group (p = 0.004 and p = 0.006, respectively). Patients with a detrusor-to-ureteral orifice distance < 7.4 mm had an 81.82% likelihood of treatment failure. Conclusion: Ultrasound measurements of the detrusor-to-ureteral orifice distance and D/U ratio proved reliable in predicting the success of endoscopic subureteric injection therapy for VUR.
- 9 March 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 46 (5) , 699-706
Subgroup analysis of accreta, increta and percreta cases using acoustic radiation force impulse elastography
Objective To compare acoustic radiation force impulse (ARFI) elastography values and histopathological diagnoses (accreta, increta, percreta) in patients suspected of having abnormal placental invasion (API). Materials and methods This prospective study included 54 patients in the third trimester with a history of caesarian section (CS) and API based on gray scale and Doppler ultrasonography (USG) and 35 healthy controls. Patients underwent ARFI elastography preoperatively. Elastography measurements of the fetal and maternal sides of the placenta were compared to histopathology. Results Patients had higher maternal‐side, fetal‐side and average elastography values (P = 0.001). Intraoperatively, eight patients (14.8%) showed abnormal cervical canal invasion and 46 (85.2%) bladder and/or parametrial invasion. Eight patients underwent CS + placental‐bed suture, 11 CS + excision of the lower segment, and 35 caesarean‐hysterectomy. Histopathology of lower segment excision/caesarian‐hysterectomy patients determined 10 (21.7%) accreta, 10 (21.7%) increta and 26 (56.6%) percreta cases. ARFI values were highest in the percreta subgroup. The increta subgroup showed higher ARFI values than the accreta subgroup but maternal‐side, fetal‐side and average ARFI values were not significantly different across the subgroups (P > 0.05). The cut‐off values for average, peripheral and central elastography were determined as >0.90, >0.76, >0.98 (m/s) with sensitivities of 98, 64, 98% and specificities of 85, 80, 91%, respectively. Conclusion ARFI elastography can detect API. However, it cannot determine invasion depth reliably. More studies with subgroup analyses are warranted to reveal its usefulness for invasion depth.
- 9 March 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 46 (5) , 699-706
Subgroup analysis of accreta, increta and percreta cases using acoustic radiation force impulse elastography
Objective To compare acoustic radiation force impulse (ARFI) elastography values and histopathological diagnoses (accreta, increta, percreta) in patients suspected of having abnormal placental invasion (API). Materials and methods This prospective study included 54 patients in the third trimester with a history of caesarian section (CS) and API based on gray scale and Doppler ultrasonography (USG) and 35 healthy controls. Patients underwent ARFI elastography preoperatively. Elastography measurements of the fetal and maternal sides of the placenta were compared to histopathology. Results Patients had higher maternal‐side, fetal‐side and average elastography values (P = 0.001). Intraoperatively, eight patients (14.8%) showed abnormal cervical canal invasion and 46 (85.2%) bladder and/or parametrial invasion. Eight patients underwent CS + placental‐bed suture, 11 CS + excision of the lower segment, and 35 caesarean‐hysterectomy. Histopathology of lower segment excision/caesarian‐hysterectomy patients determined 10 (21.7%) accreta, 10 (21.7%) increta and 26 (56.6%) percreta cases. ARFI values were highest in the percreta subgroup. The increta subgroup showed higher ARFI values than the accreta subgroup but maternal‐side, fetal‐side and average ARFI values were not significantly different across the subgroups (P > 0.05). The cut‐off values for average, peripheral and central elastography were determined as >0.90, >0.76, >0.98 (m/s) with sensitivities of 98, 64, 98% and specificities of 85, 80, 91%, respectively. Conclusion ARFI elastography can detect API. However, it cannot determine invasion depth reliably. More studies with subgroup analyses are warranted to reveal its usefulness for invasion depth.
- 19 July 2018
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 24 (2) , 86-93
Evaluation of Pulmonary Vein Variations Using Multidetector Computed Tomography
- 19 July 2018
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 24 (2) , 86-93
Evaluation of Pulmonary Vein Variations Using Multidetector Computed Tomography
- 15 July 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (4) , 456-463
The role of acoustic radiation force impulse elastography in the differentiation of benign and malignant focal liver masses
Background/Aims: The aim of this study was to evaluate elasticity of benign and malign focal liver lesions and surrounding parenchyma as measured by acoustic radiation force impulse (ARFI). Materials and Methods: 34 hemangiomas, 4 focal nodular hyperplasia (FNH), 10 hepatocellular carcinoma (HCC) and 22 metastatic lesions from a total of 62 patients were examined with ARFI elastography. ARFI measurements for each tumor type were expressed as mean ± standard deviation for liver mass and surrounding parenchyma. ARFI values were compared between tumor types and surrounding parencyhma. Results: The mean stiffness values were 2.15±0.73 m/s for hemangiomas (n=34), 3.22±0.18 m/s for FNH (n=4), 2.75±0.53 m/s for HCC (n=10) and 3.59±0.51 m/s for metastasis (n=22). Although there was not a significant difference between hemangiomas and HCC lesions in ARFI values (p>0.05), hemangiomas showed significantly different ARFI values from FNH and metastases (p<0.05). Also, there were significant differences in ARFI values between malignant and benign masses. The area under the receiver-operating characteristics curves for discriminating the malignant from benign liver masses was 0.826 (p<0.001). An ARFI value of 2.32 m/s was selected as cut-off value to differentiate malignant liver masses from benign ones (sensitivity: 0.93, specificity: 0.60). Conclusion: Although currently ARFI is not a definitive method for the primary diagnosis of focal solid liver lesions, it provides additional important information non-invasively for differential diagnosis. Cite this article as: Akdoğan E, Gelebek Yılmaz F. The role of acoustic radiation force impulse elastography in the differentiation of benign and malignant focal liver masses. Turk J Gastroenterol 2018; 29: 456-63.
- 15 July 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (4) , 456-463
The role of acoustic radiation force impulse elastography in the differentiation of benign and malignant focal liver masses
Background/Aims: The aim of this study was to evaluate elasticity of benign and malign focal liver lesions and surrounding parenchyma as measured by acoustic radiation force impulse (ARFI). Materials and Methods: 34 hemangiomas, 4 focal nodular hyperplasia (FNH), 10 hepatocellular carcinoma (HCC) and 22 metastatic lesions from a total of 62 patients were examined with ARFI elastography. ARFI measurements for each tumor type were expressed as mean ± standard deviation for liver mass and surrounding parenchyma. ARFI values were compared between tumor types and surrounding parencyhma. Results: The mean stiffness values were 2.15±0.73 m/s for hemangiomas (n=34), 3.22±0.18 m/s for FNH (n=4), 2.75±0.53 m/s for HCC (n=10) and 3.59±0.51 m/s for metastasis (n=22). Although there was not a significant difference between hemangiomas and HCC lesions in ARFI values (p>0.05), hemangiomas showed significantly different ARFI values from FNH and metastases (p<0.05). Also, there were significant differences in ARFI values between malignant and benign masses. The area under the receiver-operating characteristics curves for discriminating the malignant from benign liver masses was 0.826 (p<0.001). An ARFI value of 2.32 m/s was selected as cut-off value to differentiate malignant liver masses from benign ones (sensitivity: 0.93, specificity: 0.60). Conclusion: Although currently ARFI is not a definitive method for the primary diagnosis of focal solid liver lesions, it provides additional important information non-invasively for differential diagnosis. Cite this article as: Akdoğan E, Gelebek Yılmaz F. The role of acoustic radiation force impulse elastography in the differentiation of benign and malignant focal liver masses. Turk J Gastroenterol 2018; 29: 456-63.
- Open Access
- 1 January 2015
- Published by XMLink in Journal of Korean Medical Science
- Vol. 30 (5) , 591-597
Radiological Findings and Outcomes of Bronchial Artery Embolization in Cryptogenic Hemoptysis
Kervancioglu S, et al. J Korean Med Sci. 2015 May;30(5):591-597. http://dx.doi.org/10.3346/jkms.2015.30.5.591
- 1 January 2015
- Published by XMLink in Journal of Korean Medical Science
- Vol. 30 (5) , 591-597
Open AccessRadiological Findings and Outcomes of Bronchial Artery Embolization in Cryptogenic Hemoptysis
Kervancioglu S, et al. J Korean Med Sci. 2015 May;30(5):591-597. http://dx.doi.org/10.3346/jkms.2015.30.5.591
- 1 September 1999
- Published by Walter de Gruyter GmbH in Drug Metabolism and Drug Interactions
- Vol. 15 (2-3) , 115-126
THE IN VITRO HEPATIC MICROSOMAL METABOLISM OF N-BENZYLADAMANTANAMINE IN RATS
The metabolism of N-benzyladamantanamine (NBAD) was studied in vitro using rat hepatic microsomal preparations. The substrate and proposed metabolites were synthesized and characterized using spectroscopic techniques and separated using a reverse phase HPLC system. NBAD was incubated with rat microsomal preparations, extracted into DCM in the presence of NaCl and evaporated under a stream of nitrogen. The results from HPLC studies showed that NBAD produced the corresponding nitrone and hydroxylamine. This experiment also revealed that dealkylation occurred. No metabolites were observed which corresponded to authentic amide or oxaziridine. The reactions required a microsomal enzyme source and NADPH as a cofactor. The results indicate that the nitrone observed as a metabolite of NBAD is not an intermediate leading to the formation of an oxaziridine and hence an amide, under careful experimental conditions excluding light.
- 1 September 1999
- Published by Walter de Gruyter GmbH in Drug Metabolism and Drug Interactions
- Vol. 15 (2-3) , 115-126
THE IN VITRO HEPATIC MICROSOMAL METABOLISM OF N-BENZYLADAMANTANAMINE IN RATS
The metabolism of N-benzyladamantanamine (NBAD) was studied in vitro using rat hepatic microsomal preparations. The substrate and proposed metabolites were synthesized and characterized using spectroscopic techniques and separated using a reverse phase HPLC system. NBAD was incubated with rat microsomal preparations, extracted into DCM in the presence of NaCl and evaporated under a stream of nitrogen. The results from HPLC studies showed that NBAD produced the corresponding nitrone and hydroxylamine. This experiment also revealed that dealkylation occurred. No metabolites were observed which corresponded to authentic amide or oxaziridine. The reactions required a microsomal enzyme source and NADPH as a cofactor. The results indicate that the nitrone observed as a metabolite of NBAD is not an intermediate leading to the formation of an oxaziridine and hence an amide, under careful experimental conditions excluding light.